European ADRs Soften Amid Declines in Cellectis and Nokia Trading
What happened
On November 19, 2026, Cellectis shed 8.43% during late morning trading, making it the hardest-hit European name in the U.S. market. Nokia was the second-largest decliner in the group, falling 3.86%. DBV Technologies and Foce registered no movement on the day, while the losses contributed to a broader softening across European ADRs.
Why it matters
The trading activity illustrates an uneven environment for European names seeking U.S. capital. The broad weakness across multiple European ADRs suggests that risk appetite for non-U.S. equities remained under pressure.
Who's involved
- NokiaFinnish telecommunications company that declined 3.86% during the trading session.
- CellectisBiopharmaceutical company that experienced a sharp drop of 8.43%.
- DBV TechnologiesFrench biopharmaceutical firm that remained flat during the trading session.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
Keep exploring
The entities involved
-
Nokia
Finnish multinational telecommunications and information technology company
-
Cellectis
biopharmaceutical company
Nothing else this week.
-
DBV Technologies
publicly owned French biopharmaceutical firm headquartered in Bagneux, France
Nothing else this week.